Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SIMVASTATIN Cause Disturbance in attention? 546 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 546 reports of Disturbance in attention have been filed in association with SIMVASTATIN (Simvastatin). This represents 2.0% of all adverse event reports for SIMVASTATIN.

546
Reports of Disturbance in attention with SIMVASTATIN
2.0%
of all SIMVASTATIN reports
2
Deaths
126
Hospitalizations

How Dangerous Is Disturbance in attention From SIMVASTATIN?

Of the 546 reports, 2 (0.4%) resulted in death, 126 (23.1%) required hospitalization, and 108 (19.8%) were considered life-threatening.

Is Disturbance in attention Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 546 reports have been filed with the FAERS database.

What Other Side Effects Does SIMVASTATIN Cause?

Myalgia (3,919) Fatigue (2,066) Arthralgia (1,775) Drug interaction (1,744) Nausea (1,676) Rhabdomyolysis (1,616) Dyspnoea (1,542) Headache (1,470) Drug hypersensitivity (1,433) Muscular weakness (1,356)

What Other Drugs Cause Disturbance in attention?

LEVOTHYROXINE (1,718) METHYLPHENIDATE (1,414) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (1,321) DULOXETINE (986) PREGABALIN (950) LISDEXAMFETAMINE DIMESYLATE (911) OXYCODONE (829) QUETIAPINE (747) ACETAMINOPHEN\HYDROCODONE (746) ACETAMINOPHEN\OXYCODONE (734)

Which SIMVASTATIN Alternatives Have Lower Disturbance in attention Risk?

SIMVASTATIN vs SINGULAIR SIMVASTATIN vs SINTILIMAB SIMVASTATIN vs SIPONIMOD SIMVASTATIN vs SIPULEUCEL-T SIMVASTATIN vs SIROLIMUS

Related Pages

SIMVASTATIN Full Profile All Disturbance in attention Reports All Drugs Causing Disturbance in attention SIMVASTATIN Demographics